Nemaura Medical Inc. (NASDAQ:NMRD – Get Free Report) COO Arash Ghadar-Ghadr acquired 100,000 shares of Nemaura Medical stock in a transaction that occurred on Friday, January 5th. The shares were purchased at an average cost of $0.14 per share, with a total value of $14,000.00. Following the transaction, the chief operating officer now owns 100,000 […]
Nemaura Medical (NASDAQ:NMRD – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk. Profitability This table compares Nemaura Medical […]
Nemaura Medical (NASDAQ:NMRD – Get Free Report) and Regenicin (OTCMKTS:RGIN – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, risk, earnings, valuation, institutional ownership and dividends. Insider and Institutional Ownership 9.8% of Nemaura Medical shares […]
Nemaura Medical Inc. (NASDAQ:NMRD – Get Free Report) was the target of a large growth in short interest in August. As of August 31st, there was short interest totalling 273,300 shares, a growth of 557.0% from the August 15th total of 41,600 shares. Approximately 1.8% of the shares of the company are short sold. Based […]
Nemaura Medical Inc. (NASDAQ:NMRD – Free Report) – Stock analysts at HC Wainwright upped their Q2 2024 EPS estimates for shares of Nemaura Medical in a research note issued to investors on Monday, August 21st. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings per share of ($0.10) for the quarter, […]